Anti-CD40 Ligand Chimeric Monoclonal Antibody (Clone IDEC-131 (Toralizumab))

Anti-CD40 Ligand Chimeric Monoclonal Antibody (Clone IDEC-131 (Toralizumab))
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay37156-200 200 µg - -

6 - 10 business days*

657.00€
 
CD40 ligand (CD40L) is a type II transmembrane protein and member of the TNF superfamily encoded... more
Product information "Anti-CD40 Ligand Chimeric Monoclonal Antibody (Clone IDEC-131 (Toralizumab))"
CD40 ligand (CD40L) is a type II transmembrane protein and member of the TNF superfamily encoded by CD40LG in humans. It is expressed primarily by activated T cells, as well as activated B cells and platelets and, under inflammatory conditions, can be induced in natural killer (NK) cells, mast cells, basophils, and monocytes. CD40L trimerizes to engage its receptor, CD40, on various cells, including B cells, dendritic cells, monocytes, platelets, macrophages, endothelial cells, and myoblasts, to induce cell type-specific signaling and activities. Soluble CD40L (sCD40L) is produced by proteolytic cleavage of CD40L at the cell surface and is found in the circulation. sCD40L retains its ability to trimerize and bind to CD40, indicating CD40L can act as a cytokine. CD40L stimulates the proliferation of, and increases IgE secretion in, isolated human tonsil B cells. Immune complexes targeting CD40L induce thrombocytopenia and thrombosis in transgenic mice expressing the gene encoding the human IgG receptor (FCGR2A). Mutations in CD40LG are associated with X-linked immunodeficiency with hyper-IgM (HIGMX-1), a disorder characterized by an immunoglobulin isotype switch defect, increased serum IgM levels, ineffective T cell-B cell cooperation, and recurrent bacterial infections. Cayman's CD40 Ligand Chimeric Monoclonal Antibody (Clone IDEC-131 (Toralizumab)) was produced recombinantly from the original gp39/CD40 antibody sequence and can be used for immunofluorescence (IF). The gp39/CD40 antibody was generated by immunizing mice with a soluble fusion protein of human gp39-CD8.Synonyms: CD154, CD40L, T-B Cell-activating Molecule, T Cell Antigen Gp39, TNF Ligand Superfamily Member 5, TNF-related Activation Protein. Immunogen: Recombinant human CD40L. Clone Designation: IDEC-131 (Toralizumab). Formulation: (Request formulation change), 200 µg of protein A-affinity purified monoclonal antibody. Storage Buffer: PBS with 0.02% ProClin(TM) 300. Host: Chimeric Monoclonal Antibody. Isotype: IgG1kappa. Applications: IF, block. Cross Reactivity: (+) CD40L. UniProt Accession #: P29965.
Keywords: Anti-TRAP, Anti-CD40L, Anti-CD154, Anti-CD40LG, Anti-CD40-L, Anti-CD40 ligand, Anti-T-cell antigen Gp39, Anti-CD40 ligand, membrane form, Anti-TNF-related activation protein, Anti-sCD40L {ECO:0000303|PubMed:31331973}, Anti-Tumor necrosis factor ligand sup
Supplier: Cayman Chemical
Supplier-Nr: 37156

Properties

Application: IF, FA (blocking)
Antibody Type: Monoclonal
Clone: IDEC-131 (Toralizumab)
Conjugate: No
Host: Human
Species reactivity: human
Immunogen: Recombinant human CD40L
Format: Purified

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-CD40 Ligand Chimeric Monoclonal Antibody (Clone IDEC-131 (Toralizumab))"
Write a review
or to review a product.
Viewed